SEOM clinical guidelines in gestational trophoblastic disease (2017)

Gestational trophoblastic disease (GTD) is a rare but curable disease. Recent improvements in diagnosis and molecular biology have resulted in changes in staging and treatment. These guidelines provide evidence-based recommendation on how to manage GTD.

Detalles Bibliográficos
Autores principales: Santaballa, A., García, Y., Herrero, A., Laínez, N., Fuentes, J., De Juan, A., Rodriguez Freixinós, V., Aparicio, J., Casado, A., García-Martinez, E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2017
Materias:
Clinical Guides in Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5785593/
https://www.ncbi.nlm.nih.gov/pubmed/29149431
http://dx.doi.org/10.1007/s12094-017-1793-0
Descripción
Sumario:Gestational trophoblastic disease (GTD) is a rare but curable disease. Recent improvements in diagnosis and molecular biology have resulted in changes in staging and treatment. These guidelines provide evidence-based recommendation on how to manage GTD.

Ejemplares similares